180 related articles for article (PubMed ID: 26033043)
1. Volatile organic compounds generated by cultures of bacteria and viruses associated with respiratory infections.
Abd El Qader A; Lieberman D; Shemer Avni Y; Svobodin N; Lazarovitch T; Sagi O; Zeiri Y
Biomed Chromatogr; 2015 Dec; 29(12):1783-90. PubMed ID: 26033043
[TBL] [Abstract][Full Text] [Related]
2. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study.
Nizio KD; Perrault KA; Troobnikoff AN; Ueland M; Shoma S; Iredell JR; Middleton PG; Forbes SL
J Breath Res; 2016 Apr; 10(2):026008. PubMed ID: 27120170
[TBL] [Abstract][Full Text] [Related]
3. Volatile compounds characteristic of sinus-related bacteria and infected sinus mucus: analysis by solid-phase microextraction and gas chromatography-mass spectrometry.
Preti G; Thaler E; Hanson CW; Troy M; Eades J; Gelperin A
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):2011-8. PubMed ID: 19553163
[TBL] [Abstract][Full Text] [Related]
4. Identification of volatile organic compounds produced by bacteria using HS-SPME-GC-MS.
Tait E; Perry JD; Stanforth SP; Dean JR
J Chromatogr Sci; 2014 Apr; 52(4):363-73. PubMed ID: 23661670
[TBL] [Abstract][Full Text] [Related]
5. Resistant/susceptible classification of respiratory tract pathogenic bacteria based on volatile organic compounds profiling.
Karami N; Rezadoost H; Mirzajani F; Karimi A; Ghassempour A; Aliahmadi A; Fallah F
Cell Mol Biol (Noisy-le-grand); 2018 Jun; 64(9):6-15. PubMed ID: 30030949
[TBL] [Abstract][Full Text] [Related]
6. Identification of bacteria using volatile organic compounds.
Karami N; Karimi A; Aliahmadi A; Mirzajan F; Rezadoost H; Ghassempour A; Fallah F
Cell Mol Biol (Noisy-le-grand); 2017 Feb; 63(2):112-121. PubMed ID: 28364792
[TBL] [Abstract][Full Text] [Related]
7. Identification of microorganisms based on headspace analysis of volatile organic compounds by gas chromatography-mass spectrometry.
Boots AW; Smolinska A; van Berkel JJ; Fijten RR; Stobberingh EE; Boumans ML; Moonen EJ; Wouters EF; Dallinga JW; Van Schooten FJ
J Breath Res; 2014 Jun; 8(2):027106. PubMed ID: 24737039
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis.
Shestivska V; Dryahina K; Nunvář J; Sovová K; Elhottová D; Nemec A; Smith D; Španěl P
J Breath Res; 2015 Apr; 9(2):027104. PubMed ID: 25830686
[TBL] [Abstract][Full Text] [Related]
9. Headspace volatile organic compounds from bacteria implicated in ventilator-associated pneumonia analysed by TD-GC/MS.
Lawal O; Muhamadali H; Ahmed WM; White IR; Nijsen TME; Goodacre R; Fowler SJ
J Breath Res; 2018 Jan; 12(2):026002. PubMed ID: 28947683
[TBL] [Abstract][Full Text] [Related]
10. Characterization of volatile metabolites taken up by or released from Streptococcus pneumoniae and Haemophilus influenzae by using GC-MS.
Filipiak W; Sponring A; Baur MM; Ager C; Filipiak A; Wiesenhofer H; Nagl M; Troppmair J; Amann A
Microbiology (Reading); 2012 Dec; 158(Pt 12):3044-3053. PubMed ID: 23059976
[TBL] [Abstract][Full Text] [Related]
11. Effects of biological and methodological factors on volatile organic compound patterns during cultural growth of Mycobacterium avium ssp. paratuberculosis.
Küntzel A; Fischer S; Bergmann A; Oertel P; Steffens M; Trefz P; Miekisch W; Schubert JK; Reinhold P; Köhler H
J Breath Res; 2016 Sep; 10(3):037103. PubMed ID: 27604146
[TBL] [Abstract][Full Text] [Related]
12. Dynamic collection and analysis of volatile organic compounds from the headspace of cell cultures.
Baranska A; Smolinska A; Boots AW; Dallinga JW; van Schooten FJ
J Breath Res; 2015 Oct; 9(4):047102. PubMed ID: 26469548
[TBL] [Abstract][Full Text] [Related]
13. In vitro profiling of volatile organic compounds released by Simpson-Golabi-Behmel syndrome adipocytes.
Mochalski P; Diem E; Unterkofler K; Mündlein A; Drexel H; Mayhew CA; Leiherer A
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1104():256-261. PubMed ID: 30537625
[TBL] [Abstract][Full Text] [Related]
14. Volatile metabolites of pathogens: a systematic review.
Bos LD; Sterk PJ; Schultz MJ
PLoS Pathog; 2013 May; 9(5):e1003311. PubMed ID: 23675295
[TBL] [Abstract][Full Text] [Related]
15. Breath Markers of Oxidative Stress in Children with Severe Viral Lower Respiratory Tract Infection.
Lilien TA; Brinkman P; Fenn DW; van Woensel JBM; Bos LDJ; Bem RA
Am J Respir Cell Mol Biol; 2024 May; 70(5):392-399. PubMed ID: 38315815
[TBL] [Abstract][Full Text] [Related]
16. Investigation of atypical bacteria and virus antigens in respiratory tract infections by use of an immunofluorescence method.
Kaygusuz S; Koksal I; Aydin K; Caylan R
Jpn J Infect Dis; 2004 Apr; 57(2):33-6. PubMed ID: 15118204
[TBL] [Abstract][Full Text] [Related]
17. Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air.
Meyer N; Dallinga JW; Nuss SJ; Moonen EJ; van Berkel JJ; Akdis C; van Schooten FJ; Menz G
Respir Res; 2014 Nov; 15(1):136. PubMed ID: 25431084
[TBL] [Abstract][Full Text] [Related]
18. Cellular scent of influenza virus infection.
Aksenov AA; Sandrock CE; Zhao W; Sankaran S; Schivo M; Harper R; Cardona CJ; Xing Z; Davis CE
Chembiochem; 2014 May; 15(7):1040-8. PubMed ID: 24719290
[TBL] [Abstract][Full Text] [Related]
19. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
[TBL] [Abstract][Full Text] [Related]
20. Respiratory viruses predisposing to bacterial infections: role of neuraminidase.
Peltola VT; McCullers JA
Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S87-97. PubMed ID: 14730275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
